Efficacy and safety of twice-daily olopatadine –mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis

ConclusionGSP301 is a safe and well-tolerated medication. It showed short-term benefits for seasonal and perennial AR, but may not help to improve patients ’ quality of life and rhinitis control in the long run.
Source: European Archives of Oto-Rhino-Laryngology - Category: ENT & OMF Source Type: research